Financials
- Market Capitalization 106.01 M
- Employee 21
- Founded 2014
- CEO N/A
- Website www.blackdiamondtherapeutics.com
- Headquarter Massachusetts, United States
- FIGI BBG00MS4Y0W9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.84
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3943 | ANIX Anixa Biosciences, Inc. - Common Stock | 3.35 USD | +5.02% | +10.20% | +29.84% | +4.04% | 113.98 M USD | ||
| 3946 | KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.55 USD | 0.00% | -6.76% | +3.41% | -55.52% | 108.25 M USD | ||
| 3958 | ICCC ImmuCell Corporation - Common Stock | 11.40 USD | -2.73% | +7.85% | +19.75% | +79.81% | 103.13 M USD | ||
| 3976 | VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.85 USD | -1.35% | -11.36% | +0.34% | -2.82% | 100.50 M USD |